BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22612606)

  • 1. Quality of life and the role of menopausal hormone therapy.
    Pines A; Sturdee DW; MacLennan AH
    Climacteric; 2012 Jun; 15(3):213-6. PubMed ID: 22612606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based assessment of the impact of the WHI on women's health.
    Burger HG; MacLennan AH; Huang KE; Castelo-Branco C
    Climacteric; 2012 Jun; 15(3):281-7. PubMed ID: 22612616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy and breast cancer risk 10 years after the WHI.
    Gompel A; Santen RJ
    Climacteric; 2012 Jun; 15(3):241-9. PubMed ID: 22612610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the menopausal experiences of professional women.
    Simon JA; Reape KZ
    Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.
    Chaopotong P; Titapant V; Boriboonhirunsarn D
    J Med Assoc Thai; 2005 Dec; 88(12):1768-74. PubMed ID: 16518972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise participation, body mass index, and health-related quality of life in women of menopausal age.
    Daley A; Macarthur C; Stokes-Lampard H; McManus R; Wilson S; Mutrie N
    Br J Gen Pract; 2007 Feb; 57(535):130-5. PubMed ID: 17266830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.
    Langer RD; Manson JE; Allison MA
    Climacteric; 2012 Jun; 15(3):206-12. PubMed ID: 22612605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing women's quality of life in the later half of life.
    Chiu YW; Moore RW; Hsu CE; Huang CT; Liu HW; Chuang HY
    Climacteric; 2008 Jun; 11(3):201-11. PubMed ID: 18568785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the actual lesson from the WHI study upon its completion?].
    Pines A
    Harefuah; 2004 Oct; 143(10):722-3, 766. PubMed ID: 15521348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
    Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.